To Improve Patient Access to High-Quality Healthcare Outcomes at Lower Costs, The Federal Health Fraud Laws Need to be Changed and Simplified

Published as a three-part series

Abstract

EDITOR'S NOTE: This article is Part 1 of a 3-Part Series

Following the passage of the Affordable Care Act (hereafter, the "ACA") in 2010, the United States healthcare system began a shift from what was previously a fee-for-service reimbursement model to a value-based payment model.[1] What this meant for healthcare providers is that they would no longer be reimbursed for merely providing services to patients, but that they would instead be reimbursed for successful patient outcomes.[2] A shift in reimbursement models was needed to incentivize providers to take a long-term approach to providing high quality healthcare services to their patients rather than incentivizing higher bills to patients for various services in a marketplace where healthcare services are becoming increasingly expensive.[3],[4]

The implications of this shift in reimbursement models have several effects on the various health fraud laws that apply to providers who accept federal reimbursement dollars from Medicare, Medicaid, and the State Children's Health Insurance Program ("hereafter, S-CHIP") (hereafter, collectively "payors").[5] These health fraud laws include the Anti-Kickback Statute (hereafter, "AKS") under 42 U.S.C. section 1320a-7b(b),[6],[7] the Stark law (hereafter, Stark") 42 U.S.C. section 1395nn[8] , and the False Claims Act (hereafter, "FCA") under 31 U.S.C. sections 3729-3733[9] (multiple other state entities are involved, such as in the case in Medicaid, but the focus of this paper will be on the federal health fraud laws).[10],[11] Although originally passed to protect taxpayers from healthcare waste, fraud, and abuse, and the inherent conflicts of interest implicated if a physician is permitted to financially gain from self-referral, as is usually the case when any similar law is passed, some of the unintended consequences of these laws have included price limitations and overly-complex regulations.[12],[13] There are reasonable arguments to be made both for and against self-referrals, but overutilization of healthcare services is a very real public health problem that needs to be addressed.[14] The public's trust and patient confidence in their healthcare providers is a vital interest.[15]

Moreover, the numbers of exceptions to these laws are numerous and can make the billing and reimbursement process ever more daunting for healthcare providers.[16] Stark, for example is particularly overwhelming due to its multiple pages of exceptions.[17] Exceptions include those for physicians' services,[18] in-office ancillary services,[19] and prepaid plans,[20] among others.[21] The U.S. healthcare system is overly costly, continues to provide limited access to patients for care along with inadequate healthcare outcomes, and changes to the federal health fraud laws will help alleviate this problem by freeing up providers to coordinate on electronic medical records and focus on improved patient healthcare outcomes.

Download Full Text (PDF)


CITATION
Robinson, Michael D., To Improve Patient Access to High-Quality Healthcare Outcomes at Lower Costs, The Federal Fraud Laws Need to be Changed and Simplified, Journal of Health Care Finance (Summer 2019).

Universal Healthcare Coverage Around the Globe: Time to Bring it to the United States?

Published in the Journal of Healthcare Finance (Winter 2017)

Abstract

When it comes to providing healthcare services to its citizenry, the United States lags behind other first-world nations. The U.S. is ranked 43rd in life expectancy when compared against all the other countries of the world. Our diets and lifestyles play a significant role in our health as a nation, but our healthcare system also plays a major part. Unlike other first-world nations, the U.S. does not have a universal healthcare system that pays for and provides access to healthcare for its citizens. Instead, we have a patch-work of private insurers and federally-funded singlepayers all competing in the same market. This paper examines national healthcare systems around the world, addresses how U.S. healthcare providers are currently coping with the present situation, and then offers up a solution for our healthcare access and cost problems.

Download Full Text (PDF)

The Children’s Health Insurance Plan: The Time for Congress to Act is Now!

Published in the Journal of Healthcare Finance (Fall 2017)

Abstract

When it comes to providing healthcare services to its citizenry, the United States lags behind other first-world nations. The U.S. is ranked 43rd in life expectancy when compared against all the other countries of the world. Our diets and lifestyles play a significant role in our health as a nation, but our healthcare system also plays a major part. Unlike other first-world nations, the U.S. does not have a universal healthcare system that pays for and provides access to healthcare for its citizens. Instead, we have a patch-work of private insurers and federally-funded single payers all competing in the same market. This paper examines national healthcare systems around the world, addresses how U.S. healthcare providers are currently coping with the present situation, and then offers up a solution for our healthcare access and cost problems.

Download Full Text (PDF)

Zika Virus Outbreak Will Likely Spread To The Continental United States: Will We Be Ready For It?

Published in the DePaul College of Law: Mary and Michael Jaharis Health Law Institute: E-Pulse Newsletter (June 2016)

This spring, the media is full of stories about outbreaks of Zika virus throughout the world. The current outbreak began in Brazil last year, but just this week, a case of Zika infection was discovered in fetal tissue in Puerto Rico. The U.S. Centers for Disease Control and Prevention (“CDC”) confirmed the widespread outbreak of Zika to the island this past Friday. The CDC confirmed 925 total infections in Puerto Rico to date. Zika virus infections can cause severe birth defects in unborn fetuses.

In part to stop the spread of the virus, the U.S. Food and Drug Administration (“FDA”) recently published two separate guidance documents covering human blood donations at blood banks (dated February 2016) and human tissue donations at human tissue manufacturers (dated March 2016). Human tissues regulated by the FDA include skin, bone, reproductive tissues, corneas, ligaments, and others. Please note, FDA guidance documents are non-binding on the blood banking or human tissue manufacturing industries, but they are most often followed by industry as they generally reflect the FDA’s current thinking. Regulated industry generally, and wisely so, follows FDA guidance documents to demonstrate general compliance with all applicable regulations that carry the weight of law.

Read More


CITATION
Robinson, Michael D., Zika Virus Outbreak Will Likely Spread to the Continental United States: Will We be Ready for It?, DePaul College of Law: Mary and Michael Jaharis Health Law Institute: E-Pulse Newsletter (Jun. 2016), http://law.depaul.edu/about/centers-and-institutes/health-law-institute/newsletter/Pages/zika-virus-outbreak-spread-to-united-states.aspx.

The Invaluable Health Care Services Lien Ensure Providers Get Paid

Published in the llinois Chiropractic Society Journal (June 2016)

Health care services liens can be a valuable asset when it comes to protecting your accounts receivable from your patients’ other judgment creditors. Health care services liens have always been a feature of the law in this state, but under the Illinois Health Care Services Lien Act, the process by which liens attach (become enforceable) and perfect (establish priority over other creditors) was streamlined.1 It also incorporated in the definition of “health care professional” a number of license categories, including osteopathic, chiropractic and medical physicians, as well as other licensed providers, and discarded the patchwork of laws surrounding the process of setting up liens, which varied depending on the nature of the provider.

Under the law passed in 2003, health care liens attach “to any verdict, judgment, award, settlement, or compromise secured by or on behalf of the injured person.”2 A typical example of this may occur when a patient seeks chiropractic care as the result of a spinal injury stemming from an auto accident. The patient is treated over the course of several months but cannot afford to pay because of protracted litigation surrounding the accident. As treating doctors, chiropractors want to help their patients get better as quickly as possible. However, bills cannot go unpaid at a practice. How do you, as a provider, ensure you are paid out of the eventual settlement or jury verdict?

Read More

 

CITATION
Robinson, Michael D., The Invaluable Health Care Services Lien: Ensure Providers Get Paid, Illinois Chiropractic Society Journal, (Jun. 2016)

Toxicogenomics and Expert Witnesses in Toxic Tort Cases: A Practical Approach: A Chapter Published in: Mold: Medical & Legal Elements by Dr. Ernest P. Chiodo

Fall 2015
Published in Mold: Medical and Legal Elements, Dr. Ernest P. Chiodo
 

Chapter Abstract:

Lawyers in toxic torts litigation have a difficult burden in establishing each of the elements of a prima facie case for negligence. In such cases, it is not enough to simply go through the elements of negligence learned in law school. Particular attention must be paid to the elements of causation, and both general and specific causation need to be established. An expert witness trained and experienced in the field of toxicogenomics can help a skilled litigator successfully accomplish the client’s goals in a toxic torts case.

Toxicogenomics shows, through scientific study, what types of environmental stimuli can cause certain diseases and adverse results in a person. The field also studies the measure of exposure in specific cases involving disease. Each of these two facets of toxicogenomics can be leveraged in establishing both general and specific causation in a toxic torts case. This paper examines advances in toxicogenomics as a scientific field of study and also discusses the practical implications of the field for a lawyer in the context of a toxic torts case. An analysis of the role of the expert witness in the toxic torts case was also undertaken. This paper will demonstrate that toxicogenomics can be used by the skilled litigator to increase the likelihood of victory for the client in a toxic torts case.

Read More

Attorney Free to Publicly Criticize Ethics Commission

Published in the Illinois Civil Procedure & Professional Responsibility Blog (May 2013)

In July 2012, the United States Court of Appeals for the Sixth Circuit, in Berry v. Schmitt, ruled in favor of an attorney who publicly criticized an ethics commission for its handling of an investigation of Kentucky State Senate President David Williams. 688 F.3d 290, 294 (6th Cir. 2012).  The attorney, John Berry, alleged that his First Amendment Freedom of Speech rights1 were violated when the Kentucky Bar Association issued a warning letter to Berry for his criticism of the ethics commission. See Berry, 688 F.3d at 294.  Berry’s criticism of the Kentucky Legislative Ethics Commission stemmed from a hearing that the Ethics Commission conducted to investigate a fund-raising complaint against Senator Williams. Id.

Read More